| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.3 | 9e-09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |